Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

Foradil Aerolizer

formoterol
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Foradil Aerolizer CAPSULE, INHALATION 12 mcg    
Perforomist SOLUTION, INHALATION 20 mcg/2 mL    


Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

formoterol (Perforomist)

  • 20 mcg/2 mL solution inhalation every 12 hours

arformoterol (Brovana)

  • 15 mcg/2 mL solution inhalation every 12 hours

formoterol fumarate (Foradil)

  • 12 mcg inh BID

albuterol nebulization

  • 2.5 mg neb every 6 hours

Foradil Aerolizer medication guide

Perforomist medication guide


Perforomist (formoterol nebulization solution) is classified as non-formulary, not stocked. Interchange to Brovana (arformoterol nebulization solution).


Update:  July 13, 2016 - FORADIL discontinued by manufacturer.  Pediatric patients - contact prescriber for an alternative medication.  Formoterol is still available in combination with budesonide (SYMBICORT).  Arformoterol (BROVANA) inhalation solution is also still available.


Reviewed: September 25, 2007 (Perforomist), and 22 November 2016 (Foradil), and 24 January 2017 (Foradil)

 


Last updated: Dec. 14, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.